Predictive Oncology Inc. (NASDAQ: POAI) has priced two concurrent private placement transactions totaling approximately $344.4 million to support the launch of its new digital asset treasury strategy. The biomedical company, known for its artificial intelligence platform in cancer drug discovery, will now focus its treasury strategy on accumulating ATH, the native utility token of the Aethir ecosystem.
The financing structure includes a $51.7 million cash private investment in public equity (PIPE) and a $292.7 million crypto PIPE involving pre-funded warrants. Company officials stated the proceeds will be allocated toward ATH acquisition, working capital, and general corporate purposes. This substantial financial commitment represents one of the largest corporate treasury allocations to digital assets by a publicly-traded healthcare company.
This strategic pivot comes from a company that has established itself in the cancer research field through its scientifically validated AI platform called PEDAL. The platform demonstrates 92% accuracy in predicting whether tumor samples will respond to specific drug compounds, enabling more informed selection of drug and tumor type combinations for subsequent laboratory testing. The company's research capabilities are further supported by its extensive biobank containing more than 150,000 assay-capable heterogenous human tumor samples.
The move into digital asset treasury management signals a significant diversification for Predictive Oncology beyond its core pharmaceutical research operations. The company's decision to allocate substantial resources to cryptocurrency investments reflects growing corporate interest in digital assets as treasury instruments, though such moves remain relatively uncommon among biomedical research firms. The company maintains its headquarters in Pittsburgh, Pennsylvania, where it continues its cancer research operations alongside this new financial strategy.
For additional information about the company's operations and research initiatives, visit https://predictive-oncology.com/. The full details of the private placement announcement are available at https://ccw.fm/oIn6g.
